Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on May 15, 2025, recommended Final Dividend of 2.60 per equity share.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amrutanjan Health Care's board, at its May 15, 2025 meeting, approved audited FY25 results and recommended a final dividend of Rs. 2.60 per share on 2.89 crore equity shares, taking the total FY25 dividend to Rs. 3.60 per share (including Rs. 1 interim already paid). For FY25, revenue from operations rose about 7.3% to Rs. 451.82 crore, while profit after tax grew roughly 13% to Rs. 50.83 crore, with basic EPS at Rs. 17.58 versus Rs. 15.50 last year. Q4 FY25 revenue was Rs. 135.41 crore and PAT was Rs. 15.18 crore, both up year-on-year. The statutory auditor B S R & Co. LLP issued an unmodified opinion, and the company also announced the retirement of Company Secretary Mr. M Srinivasan on May 31, 2025, with Mr. Gagan Preet Singh taking over from June 1, 2025.
The final dividend reinforces a consistent shareholder return story, and the steady single-digit revenue growth with a low double-digit profit rise signals stable operating performance. The clean audit opinion and routine key managerial personnel change are neutral to mildly positive, with no red flags for shareholders.